| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 1.69T | 1.63T | 1.53T | 1.55T | 1.42T |
| Gross Profit | 640.98B | 638.40B | 560.43B | 548.34B | 573.19B |
| EBITDA | 256.11B | 233.44B | 189.81B | 203.47B | 240.08B |
| Net Income | 120.08B | 107.77B | 43.87B | 86.04B | 109.64B |
Balance Sheet | |||||
| Total Assets | 1.88T | 1.87T | 1.77T | 1.73T | 1.70T |
| Cash, Cash Equivalents and Short-Term Investments | 323.28B | 357.71B | 291.66B | 268.25B | 336.07B |
| Total Debt | 243.14B | 245.33B | 261.07B | 262.89B | 268.68B |
| Total Liabilities | 780.35B | 768.40B | 757.70B | 730.97B | 720.13B |
| Stockholders Equity | 1.06T | 1.07T | 983.66B | 972.06B | 965.14B |
Cash Flow | |||||
| Free Cash Flow | 138.47B | 144.18B | 148.31B | 65.39B | 115.57B |
| Operating Cash Flow | 199.68B | 201.59B | 202.48B | 130.91B | 175.52B |
| Investing Cash Flow | -69.77B | -45.90B | -109.30B | -74.91B | -67.23B |
| Financing Cash Flow | -175.13B | -104.58B | -79.98B | -139.31B | -141.57B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥1.66T | 23.99 | 10.79% | 3.47% | -1.56% | -1.15% | |
76 Outperform | ¥433.02B | 16.53 | 9.09% | 1.73% | 2.18% | 60.81% | |
71 Outperform | ¥544.30B | 13.97 | 12.66% | 1.53% | 18.35% | 31.87% | |
70 Outperform | ¥2.72T | 24.05 | 11.50% | 2.41% | 4.62% | 47.68% | |
69 Neutral | ¥331.52B | 19.79 | 2.72% | 2.61% | 1.37% | -5.60% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
56 Neutral | ¥1.17T | -22.37 | ― | 2.11% | -1.20% | -2896.72% |